Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-081587
Filing Date
2021-06-15
Accepted
2021-06-15 17:33:18
Documents
2
Period of Report
2021-06-11

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2119762-3_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2119762-3_4seq1.xml 4 4184
2 EXHIBIT 24 tm2119762d3_ex24.htm EX-24 9118
  Complete submission text file 0001104659-21-081587.txt   14524
Mailing Address
Business Address
MUELLER PETER (Reporting) CIK: 0001256126 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38410 | Film No.: 211019742

Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Issuer) CIK: 0001720893 (see all company filings)

EIN.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations